nference

Longitudinal lab test analysis confirms pre-existing anemia as a severe risk factor for post-viral clearance hospitalization in COVID-19 patients

Abstract: As the number of new and recovering cases continues to rise, it is increasingly important to understand the long-term impacts of COVID-19 beyond the time of active SARS-CoV-2 infection. We previously used augmented curation methods to analyze physician notes from a large EHR system and identified anemia and acute kidney injury as risk factors for admission to the hospital after PCR confirmation of viral clearance in COVID-19 patients. Here, we analyzed longitudinal lab testing data from this same patient cohort to determine whether these measurements corroborate our notes-derived findings. Indeed we found that COVID-19 patients hospitalized after confirmed viral clearance tended to have lower hemoglobin and hematocrit measurements both during their SARS-CoV-2 positive intervals and during the one year prior to COVID-19 diagnosis compared to patients who have not been rehospitalized after viral clearance. Further, outright laboratory-based diagnosis of moderate or severe anemia was strongly enriched in the hospitalized cohort, suggesting that anemia pre-dating or concurrent with SARS-CoV-2 infection may predispose patients to long-term complications of COVID-19. Interventions which may mitigate anemia did not reduce the risk of post clearance hospitalization, although the efficacy of and patient compliance with these interventions could not be established. This study demonstrates the value of integrated large-scale EHR analyses and highlights the need for further research to determine whether the prevention or mitigation of anemia during SARS-CoV-2 infection may reduce the risk of suffering long-term complications of COVID-19.

  • Authors:
  • Patrick Lenehan1,
  • Eshwan Ramudu1,
  • AJ Venkatakrishnan1,
  • John C. O’Horo1,
  • Andrew D. Badley2,
  • William G. Morice II2,
  • Venky Soundararajan1,
  • 1 nference, Cambridge, MA, 02142, USA
  • 2 Mayo Clinic, Rochester, MN 55905, USA
  • Correspondence:
  • Affiliations:
  • Copyright:
  • The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
  • Affiliations:
  • Copyright:
  • The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Scroll to Top